| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |